Evolving portrait of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) in Québec: an evaluation in the real-world context of care, 2013 to 2018

Notice Santécom: 126555

For many decades, the standard treatment for aortic valve stenosis was surgical aortic valve replacement (AVR). An alternative treatment has been developed that allows transcatheter implantation of a new aortic valve (TAVI).

This state of practice describes, for the period April 1, 2013 to March 31, 2018:

• the organizational structure related to TAVI;
• the characteristics of patients treated by TAVI;
• the processes of selection of patients, including wait times;
• the care processes related to TAVI and length of hospital stay;
• the main adverse events; and
• clinical outcomes following TAVI.